Skip to content

Laryngeal Mask in Morbid Obesity

Comparison of the ProSeal Laryngeal Mask and I-gel as a Temporary Ventilatory Device Before Tracheal Intubation in Morbidly Obese Patients

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04243564
Enrollment
0
Registered
2020-01-28
Start date
2021-02-15
Completion date
2022-06-15
Last updated
2023-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity

Brief summary

Investigators study the performance of both masks, Proseal Laryngeal Mask Airway (PLMA) and I-gel, as temporary ventilatory supraglottic airway devices (SGDs) before tracheal intubation in morbidly obese patients. Data are lacking in such population of patients

Detailed description

The available data regarding SGDs in morbidly obese patients have focused mainly on PLMA. In general, SGDs have been successfully used as temporary ventilatory devices before laryngoscope-guided tracheal intubation, conduits for endotracheal tube insertion, and primary airway devices during surgery. Second-generation SGDs are preferred for both rescue airway and routine use, compared with first-generation, non-gastric access devices. Data on comparison PLMA vs. I-gel in morbidly obese patient are lacking. The PLMA is a second generation gastric access SGD. PLMA is composed of an airway tube that connects to a mask which, after insertion through the patient's mouth and inflation of cuff, forms an airtight seal on top the glottis allowing a secure airway to be managed by a health care provider. PLMA can be autoclaved and reused many times. I-gel is a new type of single use, second generation, gastric access SGD and doesn't have an inflatable cuff. Because of its thermoplastic elastomer structure, it exactly adapts to the supraglottic tissue by binding with body temperature, thus minimising air leakage. The aim of this study is to compare PLMA and I-gel regarding insertion success rate, the time of insertion, gastric access tube positioning, oropharyngeal leak pressure, assessment of position by fiberoptic, ventilatory parameters and hemodynamic, and complications for each device placed before tracheal intubation in morbidly obese patients. This study is conducted at University Medical Hospital of Padova, with approval from Hospital research Ethical Committee and written informed consents from patients,. Patients are randomly allocated into 2 equal groups, according to the inclusion and exclusion criteria. PLMA (n=35) in which PLMA is used for ventilation. I-gel (n=35) in which I-gel is used for ventilation. I

Interventions

DEVICESupraglottic device (SGD)

Positioning of SGD as temporary ventilatory device before tracheal intubation

Sponsors

University of Padova
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Investigators hypothesize PLMA and I-gel are both effective as temporary ventilatory device in morbidly obese patients.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* morbidly obese patients scheduled for elective bariatric surgery under general anesthesia

Exclusion criteria

* nonfasting; symptoms or endoscopic evidence of gastroesophageal reflux, of gastric ulcer, or oropharyngeal pathology; known or predicted difficult airway; allergy to anesthetic and nonsteroidal antiinflammatory drugs; or inability to provide informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Oropharyngeal leak pressure (OLP)Procedure (After correct placement of SGD)OLP is defined as the anesthesia circuit pressure at which a gas leak occurs around the SGD

Secondary

MeasureTime frameDescription
Time insertionProcedure (Time from pick up to correct placement of SGD)Time for definitive placement of SGD
SGD placementProcedure (From pick up to correct placement of SGD)Ease of insertion of the SGD
Gastric tubeProcedure (After correct placement of SGD)Ease of insertion of the gastric tube through the dedicated conduit
fiberoptic evaluationProcedure (After correct placement of SGD and established ventilation)Fiberoptic evaluation of correct positioning through SGD
Leak fractionProcedure (After correct placement of SGD and established ventilation)The leak fraction is defined as the leak volume divided by the inspired tidal volume.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026